Medinotec Inc 8-K, filed Mar 19, 2024
Medinotec Inc. (MDNC)
About this 8-K
Medinotec Inc filed this 8-K on March 19, 2024.
Items reported
- Item 5.07: Shareholder vote results
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
|
North Riding | |
|
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: +27
|
________________________________________________ (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
SECTION 5 – Corporate Governance and Management
Item 5.07 Submission of Matters to a Vote of Security Holders.
On March 19, 2024, we held our 2023 Annual Meeting of the shareholders, at which the shareholders voted on the matters disclosed in our Proxy Statement. The final voting results for the matters submitted to a vote of the shareholders were as follows:
Proposal No. 1 - Election of Directors
Our shareholders elected the persons listed below for a one-year term expiring at our 2024 Annual Meeting or until their respective successors are duly elected and qualified:
| FOR | AGAINST | ABSTAIN | ||||||||||||||||
| Gregory Vizirgianakis | 10,205,752 | 0 | 0 | |||||||||||||||
| Pieter van Niekerk | 10,205,752 | 0 | 0 | |||||||||||||||
| Stavros G. Vizirgianakis | 10,205,752 | 0 | 0 | |||||||||||||||
| Joseph P. Dwyer | 10,205,752 | 0 | 0 | |||||||||||||||
| Athanasios Spirakis | 10,205,752 | 0 | 0 | |||||||||||||||
Proposal No. 2 – Ratification of Independent Registered Public Accounting Firm
Our shareholders did not ratify the appointment of BDO South Africa Inc. as our independent registered public accounting firm for fiscal 2024. As a result of the vote, our audit committee plans to conduct an inquiry into the reasons why ratification was not approved by the shareholders and report its findings to the board of directors for consideration.
| FOR | AGAINST | ABSTAIN | |||||||||||||
| 291,303 | 9,907,498 | 6,951 | |||||||||||||
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Medinotec, Inc.
/s/ Pieter van Niekerk
Pieter van Niekerk
Chief Financial Officer
Date March 19, 2024
| 3 |